Periodic Reporting for period 1 - FIH-IO (Development of a first-in-class inhibitor of FIH for cancer immunotherapy)

The project addresses a significant gap in current cancer treatment options by focusing on a novel approach to immunotherapy. Despite advances in immuno-oncology, current treatments like checkpoint receptor blockade are limited to a small subset of cancers and patient groups...